Skip to main content
Erschienen in: Acta Neurochirurgica 10/2009

01.10.2009 | Clinical Article

Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection

verfasst von: Alessio Albanese, Pasquale De Bonis, Giovanni Sabatino, Gennaro Capone, Enrico Marchese, Andrea Vignati, Giulio Maira

Erschienen in: Acta Neurochirurgica | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the efficacy of antibiotic impregnated shunts (AIS) in reducing shunt infections in a population at high risk of shunt infection.

Methods

From October 2005 to October 2007, patients at high risk of infection (severely disabled, not able to take care of themselves, frequent nosocomial infections) were selected from the 198 adults who underwent shunt placement.

Results

Eighteen adults were identified (mean age 61.8 years). Six patients had AISs, and 12 patients had non-AISs. Groups did not differ in age, sex, type of hydrocephalus or hospital stay before shunting. Shunt infection occurred in 7/12 cases of the non-AIS group (58.3%) versus no infections in the AIS group. In six of seven cases, infection occurred within the first 6 months after surgery. A prevalence of S. epidermidis was detected.

Conclusions

We believe that in these patients AIS could be effective. Larger, prospective studies are needed in order to definitely address this issue.
Literatur
1.
Zurück zum Zitat Choux M, Genitori L, Lang D, Lena G (1992) Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875–880CrossRefPubMed Choux M, Genitori L, Lang D, Lena G (1992) Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77:875–880CrossRefPubMed
4.
Zurück zum Zitat George R, Leibrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804–811CrossRefPubMed George R, Leibrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804–811CrossRefPubMed
5.
Zurück zum Zitat Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831–839CrossRefPubMed Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831–839CrossRefPubMed
7.
Zurück zum Zitat Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195–201CrossRefPubMed Kulkarni AV, Drake JM, Lamberti-Pasculli M (2001) Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 94:195–201CrossRefPubMed
8.
Zurück zum Zitat Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE (2007) Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 8:7–38 Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE (2007) Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 8:7–38
9.
Zurück zum Zitat Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131–136PubMed Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131–136PubMed
10.
Zurück zum Zitat Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI (2007) Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23:867–871. doi:10.1007/s00381-007-0334-5 CrossRefPubMed Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI (2007) Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23:867–871. doi:10.​1007/​s00381-007-0334-5 CrossRefPubMed
11.
Zurück zum Zitat Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI (2007) Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 15(22):E9 Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI (2007) Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 15(22):E9
13.
Zurück zum Zitat Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56–61. doi:10.1007/s00381-004-1052-x CrossRefPubMed Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56–61. doi:10.​1007/​s00381-004-1052-x CrossRefPubMed
15.
Zurück zum Zitat Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52(5):605–609. doi:10.1136/jnnp.52.5.605 CrossRefPubMed Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52(5):605–609. doi:10.​1136/​jnnp.​52.​5.​605 CrossRefPubMed
16.
Zurück zum Zitat Bayston R, Lambert E (1997) Duration of activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent catheter -related infection. J Neurosurg 87(2):247–251CrossRefPubMed Bayston R, Lambert E (1997) Duration of activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent catheter -related infection. J Neurosurg 87(2):247–251CrossRefPubMed
18.
Zurück zum Zitat Tamburrini G, Massimi L, Caldarelli M, Di Rocco C (2008) Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours. Acta Neurochir (Wien) 150(10):1049–1056. doi:10.1007/s00701-008-0022-6 CrossRef Tamburrini G, Massimi L, Caldarelli M, Di Rocco C (2008) Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours. Acta Neurochir (Wien) 150(10):1049–1056. doi:10.​1007/​s00701-008-0022-6 CrossRef
Metadaten
Titel
Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection
verfasst von
Alessio Albanese
Pasquale De Bonis
Giovanni Sabatino
Gennaro Capone
Enrico Marchese
Andrea Vignati
Giulio Maira
Publikationsdatum
01.10.2009
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 10/2009
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-009-0317-2

Weitere Artikel der Ausgabe 10/2009

Acta Neurochirurgica 10/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.